2. Immunology/Inflammation
  3. VAP-1
  4. VAP-1-IN-2

VAP-1-IN-2 是一种具有口服活性 VAP-1 抑制剂，对人源的 IC50 值为 0.025 μM，对大鼠的 IC50 值为 0.015 μM。VAP-1-IN-2 可抑制糖尿病大鼠的尿蛋白排泄和蛋白尿进展。VAP-1-IN-2在大鼠中抑制 VAP-1 活性。VAP-1-IN-2 可用于糖尿病、肾病的相关研究。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

VAP-1-IN-2

VAP-1-IN-2 Chemical Structure

CAS No. : 1279026-89-9

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

VAP-1-IN-2 相关抗体

Top Publications Citing Use of Products

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

VAP-1-IN-2 is an orally active VAP-1 inhibitor with an IC50 value of 0.025 μM against human VAP-1 and 0.015 μM against rat VAP-1. VAP-1-IN-2 inhibits urinary protein excretion and the progression of proteinuria in diabetic rats. VAP-1-IN-2 inhibits VAP-1 activity in rats. VAP-1-IN-2 can be used in research related to diabetes and nephropathy[1][2].

体外研究
(In Vitro)

VAP-1-IN-2 (Compound 1/17hd) 可强效抑制重组人源 VAP-1，其 IC50 为 0.025 μM；同时可强效抑制重组大鼠源 VAP-1，其 IC50 为 0.015 μM[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

VAP-1-IN-2 相关抗体:
药代动力学
(Parmacokinetics)
Species Dose Route AUC0-24 CLtotal T1/2 Vdss Cmax Bioavailability
Rat[2] 1 mg/kg i.v. 1920 ng·h/mL 8.69 mL/min/kg 1.39 h 0.386 L/kg / /
Rat[2] 1 mg/kg p.o. 334 ng·h/mL / 1.29 h / 113 ng/mL 17.4 %
体内研究
(In Vivo)

VAP-1-IN-2 (0.3-1 mg/kg；口服；单次给药) 可在大鼠中抑制 VAP-1 活性[1][2]。
VAP-1-IN-2 (0.3-1 mg/kg；口服；每日 1 次；持续 4 周) 可显著抑制 Streptozotocin (HY-13753) 诱导的糖尿病大鼠的蛋白尿进展及血浆 VAP-1 活性[2]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Sprague-Dawley (male)/Wistar (male)[1]
Dosage: 0.3 mg/kg/0.3 mg/kg; 1 mg/kg
Administration: p.o.; single dose
Result: Inhibited rat plasma VAP-1 activity by 92% at 1 hour post-dose.
Inhibited rat plasma VAP-1 activity by 74% at 6 hours post-dose.
Inhibited plasma VAP-1 activity by 64% at 1 hour post-dose and 62% at 6 hours post-dose (0.3 mg/kg).
Inhibited plasma VAP-1 activity by 96% at 1 hour post-dose and 93% at 6 hours post-dose (1 mg/kg).
Animal Model: Sprague Dawley (SD) (male, 6 weeks old; streptozotocin-induced diabetes)[2]
Dosage: 0.3 mg/kg; 1 mg/kg
Administration: p.o.; once daily; 4 weeks
Result: Significantly inhibited the progression of proteinuria compared to the STZ control group (0.3 mg/kg and 1 mg/kg).
Significantly inhibited plasma VAP-1 activity in STZ-induced diabetic rats 24 hours after the final dose (0.3 mg/kg and 1 mg/kg).
分子量

494.98

Formula

C25H27ClN6O3
CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

VAP-1-IN-2 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

VAP-1-IN-21279026-89-9VAP-1Vascular adhesion protein-1 (VAP-1)Semicarbazide-sensitive amine oxidase (SSAO)Amine oxidase copper-containing 3 (AOC3)VAP-1 inhibitorSprague-Dawley ratWistar ratdiabetesnephropathyInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
VAP-1-IN-2
目录号：
HY-153506
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z